Clinic
NPI deactivated
Family Care Walk in Clinic, INC.
Family Care Walk in Clinic, INC. was paid $6.25M by Medicaid between Jan 2018 and Dec 2024, across 55 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.
33Billing provider infoFAMILY CARE WALK IN CLINIC, INC.
JACKSON, TN 38305
JACKSON, TN 38305
33aNPI1457302598assigned 05/13/2006
33bProvider typeRural Health Clinic/Center
28Total paid$6.25M
24GClaims219,230
24DCodes billed55
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Health Clinic/Center providers in Tennessee
Rank by total paid#5 of 96
Median peer was paid$127K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,148 | $661K | |
| 2019 | 28,882 | $727K | |
| 2020 | 28,034 | $781K | |
| 2021 | 43,412 | $1.29M | |
| 2022 | 41,682 | $1.26M | |
| 2023 | 31,336 | $952K | |
| 2024incomplete | 18,736 | $575K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 50% | 55,581 | 47,000 | $3.13M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 27,336 | 24,593 | $1.06M |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 6.7% | 11,537 | 10,614 | $420K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.7% | 14,199 | 9,611 | $233K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.2% | 14,321 | 12,084 | $201K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.9% | 6,686 | 2,228 | $180K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.7% | 2,679 | 2,360 | $166K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 13,846 | 12,082 | $125K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.9% | 5,336 | 1,758 | $118K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.7% | 1,126 | 1,018 | $104K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 15,418 | 12,648 | $89K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,226 | 1,606 | $61K |
43 more codes
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 2,516 | $51K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 697 | $51K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 843 | $39K |
| 87428 | <1% | 632 | $30K | |
| 96160 | <1% | 1,806 | $19K | |
| 96127 | <1% | 4,566 | $17K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 625 | $17K |
| 36416 | <1% | 12,449 | $14K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 2,232 | $12K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 579 | $12K |
| 90837 | Psychotherapy session, about an hour | <1% | 152 | $10K |
| 81003 | <1% | 6,662 | $10K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 148 | $9K |
| 99173 | <1% | 2,027 | $9K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 827 | $9K |
| 81025 | <1% | 1,817 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 569 | $7K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 80 | $5K |
| 97162 | <1% | 94 | $5K | |
| 92551 | <1% | 613 | $4K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 38 | $3K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,258 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 4,582 | $2K |
| 99423 | <1% | 48 | $1K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 873 | $1K |
| 36415 | Collection of venous blood by venipuncture | <1% | 763 | $1K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 14 | $1K |
| 97161 | <1% | 12 | $704.46 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 89 | $573.46 |
| 99422 | <1% | 22 | $462.93 | |
| 97035 | <1% | 64 | $459.42 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 33 | $440.10 |
| 3077F | <1% | 253 | $336.40 | |
| 3080F | <1% | 307 | $333.66 | |
| 90686 | <1% | 14 | $287.62 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 16 | $230.74 |
| 90756 | <1% | 13 | $191.92 | |
| 3074F | <1% | 207 | $180.00 | |
| 3079F | <1% | 181 | $163.20 | |
| 3078F | <1% | 96 | $120.00 | |
| 3075F | <1% | 95 | $100.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $99.27 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 13 | $0.59 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBEUERLEIN, JEFFREY (OWNER)